Takeda Pharmaceutical
TAK
#431
Rank
HK$437.65 B
Marketcap
HK$138.53
Share price
1.78%
Change (1 day)
36.64%
Change (1 year)

EPS for Takeda Pharmaceutical (TAK)

EPS in 2025 (TTM): HK$4.40

According to Takeda Pharmaceutical's latest financial reports the company's current EPS (TTM) is HK$4.38. a decrease over its 2024 EPS that were of HK$2.38.

EPS history for Takeda Pharmaceutical from 2000 to 2025

Annual EPS

Year EPS Change
2025HK$1.78-25.03%
2024HK$2.38-60.3%
2023HK$5.9826.77%
2022HK$4.72-44.4%
2021HK$8.49722.5%
2020HK$1.03-79.14%
2019HK$4.95-43.73%
2018HK$8.7970.24%
2017HK$5.1645.47%
2016HK$3.55-158.86%
2015-HK$6.03-217.99%
2014HK$5.11-34.43%
2013HK$7.795.17%
2012HK$7.41-49.61%
2011HK$14.71-6.27%
2010HK$15.6936.82%
2009HK$11.47-28.28%
2008HK$15.9924.96%
2007HK$12.809.24%
2006HK$11.723.21%
2005HK$11.35-6.29%
2004HK$12.1118.8%
2003HK$10.2030.39%
2002HK$7.8252.45%
2001HK$5.131.77%
2000HK$5.04

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
HK$81.52 1,759.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
HK$57.48 1,211.28%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Pfizer
PFE
HK$13.43 206.44%๐Ÿ‡บ๐Ÿ‡ธ USA
Amgen
AMGN
HK$101.75 2,221.47%๐Ÿ‡บ๐Ÿ‡ธ USA
Sanofi
SNY
HK$28.94 560.22%๐Ÿ‡ซ๐Ÿ‡ท France
Merck
MRK
HK$59.30 1,252.93%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
HK$28.08 540.66%๐Ÿ‡ฌ๐Ÿ‡ง UK
Seagen
SGEN
-HK$31.31-814.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Dr. Reddy's Laboratories
RDY
HK$6.36 45.11%๐Ÿ‡ฎ๐Ÿ‡ณ India